JNJ Covered Call Strategy
JNJ (Johnson & Johnson), in the Healthcare sector, (Drug Manufacturers - General industry), listed on NYSE.
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
JNJ (Johnson & Johnson) trades in the Healthcare sector, specifically Drug Manufacturers - General, with a market capitalization of approximately $554.67B, a trailing P/E of 26.78, a beta of 0.26 versus the broader market, a 52-week range of 147.33-251.71, average daily share volume of 8.0M, a public-listing history dating back to 1943, approximately 138K full-time employees. These structural characteristics shape how JNJ stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.26 indicates JNJ has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure. JNJ pays a dividend, which adjusts put-call parity and shifts the ex-dividend pricing across the listed chain.
What is a covered call on JNJ?
A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income.
Current JNJ snapshot
As of May 15, 2026, spot at $227.34, ATM IV 21.53%, IV rank 54.12%, expected move 6.17%. The covered call on JNJ below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 28-day expiry.
Why this covered call structure on JNJ specifically: JNJ IV at 21.53% is mid-range versus its 1-year history, so the credit collected on a JNJ covered call sits in line with its long-run distribution, with a market-implied 1-standard-deviation move of approximately 6.17% (roughly $14.03 on the underlying). The 28-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated JNJ expiries trade a higher absolute premium for lower per-day decay. Position sizing on JNJ should anchor to the underlying notional of $227.34 per share and to the trader's directional view on JNJ stock.
JNJ covered call setup
The JNJ covered call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With JNJ near $227.34, the first option leg uses a $240.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed JNJ chain at a 28-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 JNJ shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 100 shares | Stock | $227.34 | long |
| Sell 1 | Call | $240.00 | $1.22 |
JNJ covered call risk and reward
- Net Premium / Debit
- -$22,612.00
- Max Profit (per contract)
- $1,388.00
- Max Loss (per contract)
- -$22,611.00
- Breakeven(s)
- $226.12
- Risk / Reward Ratio
- 0.061
Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium.
JNJ covered call payoff curve
Modeled P&L at expiration across a range of underlying prices for the covered call on JNJ. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -100.0% | -$22,611.00 |
| $50.28 | -77.9% | -$17,584.50 |
| $100.54 | -55.8% | -$12,557.99 |
| $150.81 | -33.7% | -$7,531.49 |
| $201.07 | -11.6% | -$2,504.99 |
| $251.34 | +10.6% | +$1,388.00 |
| $301.60 | +32.7% | +$1,388.00 |
| $351.87 | +54.8% | +$1,388.00 |
| $402.13 | +76.9% | +$1,388.00 |
| $452.40 | +99.0% | +$1,388.00 |
When traders use covered call on JNJ
Covered calls on JNJ are an income strategy run on existing JNJ stock positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.
JNJ thesis for this covered call
The market-implied 1-standard-deviation range for JNJ extends from approximately $213.31 on the downside to $241.37 on the upside. A JNJ covered call collects premium on an existing long JNJ position, trading off upside above the short call strike for immediate income; the short strike selection should reflect the trader's view on whether JNJ will breach that level within the expiration window. Current JNJ IV rank near 54.12% is mid-range against its 1-year distribution, so the IV signal is neutral; the covered call thesis on JNJ should anchor more to the directional view and the expected-move geometry. As a Healthcare name, JNJ options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to JNJ-specific events.
JNJ covered call positions are structurally neutral to slightly bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. JNJ positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move JNJ alongside the broader basket even when JNJ-specific fundamentals are unchanged. Short-premium structures like a covered call on JNJ carry tail risk when realized volatility exceeds the implied move; review historical JNJ earnings reactions and macro stress periods before sizing. Always rebuild the position from current JNJ chain quotes before placing a trade.
Frequently asked questions
- What is a covered call on JNJ?
- A covered call on JNJ is the covered call strategy applied to JNJ (stock). The strategy is structurally neutral to slightly bullish: A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income. With JNJ stock trading near $227.34, the strikes shown on this page are snapped to the nearest listed JNJ chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are JNJ covered call max profit and max loss calculated?
- Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium. For the JNJ covered call priced from the end-of-day chain at a 30-day expiry (ATM IV 21.53%), the computed maximum profit is $1,388.00 per contract and the computed maximum loss is -$22,611.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a JNJ covered call?
- The breakeven for the JNJ covered call priced on this page is roughly $226.12 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current JNJ market-implied 1-standard-deviation expected move is approximately 6.17%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a covered call on JNJ?
- Covered calls on JNJ are an income strategy run on existing JNJ stock positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.
- How does current JNJ implied volatility affect this covered call?
- JNJ ATM IV is at 21.53% with IV rank near 54.12%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.